According to Syndax Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$0.4 B. In 2023 the company made an earning of -A$0.32 B a decrease over its 2022 earnings that were of -A$0.23 B.The earnings displayed on this page is the company's Pretax Income.